Fanuc Robots 'Ease Pain' For Takeda Pharmaceutical
Fanuc robots 'ease pain' for Takeda Pharmaceutical February 7, 2025 by Mark Allinson A collaborative robotic solution from Fanuc ...
pharmaphorum6d
The FDA’s Guidance on Labels and Cartons: yet another attack on pharmaceutical trade dress?
In the Guidance, the FDA posits that poor pharmaceutical label design can contribute to medication errors. To reduce such errors, the FDA seemingly takes a "pro-trade dress" stance by warning ...
Nasdaq8d
Astellas Pharma : FDA Approves Expanded Label For IZERVAY For Geographic Atrophy
(RTTNews) - Astellas Pharma Inc. (ALPMY ... and patients with greater flexibility when managing GA. The approved label update was based on positive results from the GATHER2 Phase 3 clinical ...
Finanznachrichten7d
Astellas Pharma Inc.: U.S. FDA Approves Expanded Label for Astellas' IZERVAY (avacincaptad pegol intravitreal solution) for Geographic Atrophy
TOKYO, Feb. 12, 2025 /PRNewswire/ -- Astellas Pharma Inc. (TSE ... slowing of GA across two pivotal studies." The approved label update was based on positive results from the GATHER2 Phase ...
Contract Pharma15d
Bio-Rad Launches Dye Label Kits for Antibody Conjugation
Bio-Rad Laboratories, Inc., a global life science research and clinical diagnostics products company, launched its TrailBlazer Tag and TrailBlazer StarBright Dye Label Kits. The new kits are designed ...
The American Journal of Managed Care3d
The Role of Private Label Agreements in Enhancing Access to Biosimilars
Panelists discuss how private label agreements facilitate biosimilar market entry by allowing manufacturers to collaborate on branding, distribution, and market access, ultimately expanding treatment ...